CLOVER BIOPHARMACEUTICALS
Clover Biopharmaceuticals is a global, clinical-stage, research-based biotechnology company focused on discovering, developing and commercializing transformative biologic therapies, with a focus on oncology and autoimmune diseases. Clover is utilizing its proprietary Trimer-Tag© technology platform to develop novel biologics targeting trimerization-dependent pathways. Additionally, Clover is leveraging its in-house cGMP biomanufacturing capabilities to develop select biosimilars.
CLOVER BIOPHARMACEUTICALS
Industry:
Biotechnology Clinical Trials Health Care Pharmaceutical
Founded:
2007-01-01
Address:
Chengdu, Sichuan, China
Country:
China
Website Url:
http://www.cloverbiopharma.com
Total Employee:
251+
Status:
Active
Contact:
+86 (028)85336933
Email Addresses:
[email protected]
Total Funding:
343.65 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Mobile Non Scaleable Content Euro IPv6 ReCAPTCHA COVID-19 ReCAPTCHA V2 Java EE Akamai Hosted
Current Employees Featured
Founder
Stock Details
Investors List
Oceanpine Capital
Oceanpine Capital investment in Series C - Clover Biopharmaceuticals
Temasek Holdings
Temasek Holdings investment in Series C - Clover Biopharmaceuticals
OrbiMed
OrbiMed investment in Series C - Clover Biopharmaceuticals
Delos Capital
Delos Capital investment in Series C - Clover Biopharmaceuticals
GL Ventures
GL Ventures investment in Series C - Clover Biopharmaceuticals
GL Ventures
GL Ventures investment in Series B - Clover Biopharmaceuticals
Beida Biomedical Industry Fund
Beida Biomedical Industry Fund investment in Series B - Clover Biopharmaceuticals
Lapam Capital
Lapam Capital investment in Series B - Clover Biopharmaceuticals
Sichuan Province Healthy Pension Industry Equity Investment Fund
Sichuan Province Healthy Pension Industry Equity Investment Fund investment in Series B - Clover Biopharmaceuticals
Zhongguancun VC Development Center
Zhongguancun VC Development Center investment in Series B - Clover Biopharmaceuticals
Key Employee Changes
| Date | New article |
|---|---|
| 2022-06-30 | Clover Announces Executive Leadership Appointments |
Official Site Inspections
http://www.cloverbiopharma.com Semrush global rank: 4.37 M Semrush visits lastest month: 2.58 K
- Host name: 139.196.184.175
- IP address: 139.196.184.175
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
More informations about "Clover Biopharmaceuticals" on Search Engine
Clover Biopharmaceuticals | Home
Jan 16, 2023. Clover Provides Updates on COVID-19 Vaccine Commercial Launch and Strategic Priorities in 2023. Our mission is to leverage our Trimer-Tag technology and in …See details»
Clover Biopharmaceuticals | Our Company
Clover Biopharmaceuticals | Our Company. English. Our Company. We are a global commercial-stage biotechnology company committed to unleashing the power of …See details»
Clover Provides Update on 2022 Corporate Milestones
SHANGHAI, China, Oct. 09, 2022 (GLOBE NEWSWIRE) -- Clover Biopharmaceuticals, Ltd. (Clover; HKEX: 02197), a global clinical-stage biotechnology company developing …See details»
Clover Biopharmaceuticals | Our Leadership
Our Leadership. Our global leadership team drives Clover's culture of innovation and ambition to improve health and save lives. Leadership. Board of Directors. Vaccine Scientific. Advisory Board. Clover …See details»
Press Release Details - Clover Biopharmaceuticals, Ltd.
Mar 29, 2023 Clover Biopharmaceuticals is a global commercial-stage biotechnology company committed to unleashing the power of innovative vaccines to save lives and …See details»
Clover Biopharmaceuticals | LinkedIn
Clover Biopharmaceuticals | 7,081 followers on LinkedIn. Unleashing the power of innovative vaccines to save lives and improve health around the world | Founded in …See details»
Clover’s Universal COVID-19 Booster Vaccine Candidate
Sep 19, 2022 Clover Biopharmaceuticals is a global clinical-stage biotechnology company committed to developing novel vaccines and biologic therapeutics. The Trimer …See details»
Investor Relations | Clover Biopharmaceuticals, Ltd.
We are a global commercial-stage biotechnology company committed to unleashing the power of innovative vaccines to save lives and improve health around the world. With …See details»
Press Release Details - Clover Biopharmaceuticals, Ltd.
CHENGDU, China, and OSLO, Norway, September 22, 2021 – Clover Biopharmaceuticals, Ltd. (Clover), a global clinical-stage biotechnology company …See details»
Press Release Details - Clover Biopharmaceuticals, Ltd.
SHANGHAI, China, Sept. 20, 2022 (GLOBE NEWSWIRE) -- Clover Biopharmaceuticals, Ltd. (Clover; HKEX: 02197), a global clinical-stage biotechnology company developing …See details»
Clover’s COVID-19 Vaccine Candidate Receives European Union …
Sep 20, 2022 Clover Biopharmaceuticals is a global clinical-stage biotechnology company committed to developing novel vaccines and biologic therapeutics. The Trimer …See details»
Clover Biopharmaceuticals | Our Pipeline
Our Pipeline. Our diverse pipeline is designed to meaningfully reduce the burden of vaccine-preventable diseases—and to make more diseases preventable. Vaccines. Other …See details»
Clover Biopharmaceuticals - Crunchbase Company Profile
Clover Biopharmaceuticals is a global, clinical-stage, research-based biotechnology company focused on discovering, developing and commercializing transformative …See details»
Clover Biopharmaceuticals | Our Culture
Clover Biopharmaceuticals | Our Culture. Our Culture. A company is its people. We are proud of our community and excited to share it with you. At Clover, you can leverage the …See details»
clover Biopharmaceuticals: Clover says its COVID-19 vaccine …
Sep 22, 2021 A potential COVID-19 vaccine from China 's Clover Biopharmaceuticals was 67% effective against COVID-19 and 79% against the highly infectious Delta variant …See details»
Financial Reports | Clover Biopharmaceuticals, Ltd.
Financial Reports. 2023 Interim Report. 2023-09. 2022 Annual Report. 2023-04. 2022 Interim Report. 2022-09. 2021 Annual Report.See details»
Clover Biopharmaceuticals' COVID-19 vaccine study underway
5 days ago Clover Biopharmaceuticals, a global clinical-stage biotechnology company, announced on Tuesday the completion of targeted enrollment of adult and elderly …See details»
Clover Biopharmaceuticals | CipherBio
Clover Biopharmaceuticals is a global, clinical-stage, research-based biotechnology company focused on discovering, developing and commercializing transformative …See details»
Clover Biopharmaceuticals - Funding, Financials, Valuation
Clover Biopharmaceuticals is registered under the ticker HKG:2197 . Their stock opened with HK$13.38 in its Nov 5, 2021 IPO. Clover Biopharmaceuticals is funded by 12 …See details»
Clover Biopharmaceuticals | Devex
Room B-A10, Building 1 Tianhe Incubator, Chengdu Hi-Tech Park South Tian Fu Avenue 610041 Chengdu, China. Learn more about Clover Biopharmaceuticals's jobs, …See details»